Notices. Notice; correction
224 words·~1 min read·
/register/2017/07/10/2017-14365·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-1486] Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection of Zika Virus; Availability; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration is correcting a notice entitled “Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection of Zika Virus; Availability” that appeared in the **Federal Register** of June 30, 2017 (82 FR 29886).
The document announced the issuance of two Emergency Use Authorizations for in vitro diagnostic devices for detection of the Zika virus in response to the Zika virus outbreak in the Americas. The document was published with the incorrect docket number. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.
SUPPLEMENTARY INFORMATION: In the **Federal Register** of Friday, June 30, 2017, in FR Doc. 2017-13720, on page 29866, the following correction is made: 1. On page 29866, in the first column, in the headings section at the beginning of the document, the docket number is corrected to read “FDA-2016-N-1486”. Dated: June 30, 2017. Anna K. Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis. [FR Doc. 2017-14365 Filed 7-7-17; 8:45 am]